{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:02:34Z","timestamp":1777752154133,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Foundation of Fujian University of Traditional Chinese Medicine"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20784"],"award-info":[{"award-number":["U24A20784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473812"],"award-info":[{"award-number":["82473812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":""Select the best candidates to lead key research projects" of Fujian University of Traditional Chinese Medicine","award":["XJB2022008"],"award-info":[{"award-number":["XJB2022008"]}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Frontier Technology Platform for Research Projects of Liaoning Provincial Department of Education in 2024","award":["LJ232410163056"],"award-info":[{"award-number":["LJ232410163056"]}]},{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["X2023001"],"award-info":[{"award-number":["X2023001"]}],"id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108622","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:06:36Z","timestamp":1747911996000},"page":"108622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An NTCP-mediated liver-targeting chimeras (NTLiverTac) design strategy and its application to hepatoblastoma models"],"prefix":"10.1016","volume":"162","author":[{"given":"Jing","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siting","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108622_bb0005","article-title":"The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution","volume":"69","author":"O'Neill","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.bioorg.2025.108622_bb0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","article-title":"Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)","volume":"49","author":"Semeraro","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108622_bb0015","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2002.06.102","article-title":"Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group","volume":"20","author":"Czauderna","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0020","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1200\/JCO.2002.06.155","article-title":"Hepatocellular carcinoma in children and adolescents: results from the pediatric oncology group and the children\u2019s Cancer group intergroup study","volume":"20","author":"Katzenstein","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26701","article-title":"Complete remission of refractory hepatoblastoma after liver transplantation in a child with sorafenib monotherapy: a new hope?","volume":"64","author":"Shanmugam","year":"2017","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.bioorg.2025.108622_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108622_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102644","article-title":"Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: a future perspective at a time of rapidly changing treatment paradigms","volume":"52","author":"Chen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioorg.2025.108622_bb0040","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/acs.jmedchem.1c01265","article-title":"Stabilization of the RAS:PDE6D complex is a novel strategy to inhibit RAS signaling","volume":"65","author":"Yelland","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0045","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.jmedchem.3c01468","article-title":"Discovery of novel PROTAC degraders of p300\/CBP as potential therapeutics for hepatocellular carcinoma","volume":"67","author":"Chang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116978","article-title":"Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma","volume":"280","author":"Ai","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0055","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3389\/fonc.2019.01471","article-title":"Targeting BET proteins with a PROTAC molecule elicits potent anticancer activity in HCC cells","volume":"9","author":"Zhang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400109","article-title":"Folate-PEG-PROTAC micelles for enhancing tumor-specific targeting proteolysis in vivo","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"Suppl. 2","key":"10.1016\/j.bioorg.2025.108622_bb0070","first-page":"S145","article-title":"The concise guide to PHARMACOLOGY 2023\/24: ion channels","volume":"180","author":"Alexander","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0075","series-title":"Identification of PDE6D as a potential target of sorafenib via PROTAC technology, bioRxiv","author":"Li","year":"2020"},{"key":"10.1016\/j.bioorg.2025.108622_bb0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2024.08.044","article-title":"Liver-targeting chimeras as a potential modality for the treatment of liver diseases","volume":"374","author":"Chen","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioorg.2025.108622_bb0090","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/jacs.1c00451","article-title":"Cancer selective target degradation by folate-caged PROTACs","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108622_bb0095","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1021\/acsnano.2c10379","article-title":"Aptamer-based targeted protein degradation","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2025.108622_bb0100","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Antitumor effect of anti-c-Myc aptamer-based PROTAC for degradation of the c-Myc protein","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bioorg.2025.108622_bb0105","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1039\/D2CS00141A","article-title":"Degrader-antibody conjugates","volume":"51","author":"Dragovich","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2025.108622_bb0110","doi-asserted-by":"crossref","first-page":"14155","DOI":"10.1021\/jacs.3c05159","article-title":"Bioorthogonal PROTAC prodrugs enabled by on-target activation","volume":"145","author":"Chang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108622_bb0115","article-title":"Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma","volume":"10","author":"Ji","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2025.108622_bb0120","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acs.jmedchem.2c01337","article-title":"Metabolically stable anomeric linkages containing GalNAc-siRNA conjugates: an interplay among ASGPR, glycosidase, and RISC pathways","volume":"66","author":"Kandasamy","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","article-title":"Bifunctional small molecules that mediate the degradation of extracellular proteins","volume":"17","author":"Caianiello","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41586-022-04723-z","article-title":"Structural basis of sodium-dependent bile salt uptake into the liver","volume":"606","author":"Goutam","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108622_bb0135","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.2174\/0109298673274040231121113410","article-title":"Bile acid-conjugate as a promising anticancer agent: recent Progress","volume":"31","author":"Rathod","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0140","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1053\/gast.1997.v113.pm9322525","article-title":"Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas","volume":"113","author":"Kullak-Ublick","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioorg.2025.108622_bb0145","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0168-8278(03)00393-3","article-title":"NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver","volume":"39","author":"Fiorucci","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2025.108622_bb0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/aps.2011.7","article-title":"Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: synthesis and biological characterization","volume":"32","author":"Chen","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2025.108622_bb0155","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jps.22332","article-title":"Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT)","volume":"100","author":"Rais","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108622_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-017-1892-z","article-title":"Novel adefovir mono L-amino acid ester, mono bile acid ester derivatives: design, synthesis, biological evaluation, and molecular docking study","volume":"26","author":"Chen","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108622_bb0165","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1021\/acs.jmedchem.1c00649","article-title":"Rational design and synthesis of novel dual PROTACs for simultaneous degradation of EGFR and PARP","volume":"64","author":"Zheng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0170","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acs.jnatprod.2c00912","article-title":"Synthesis of Lathyrol PROTACs and evaluation of their anti-inflammatory activities","volume":"86","author":"Wang","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108622_bb0175","doi-asserted-by":"crossref","first-page":"107762","DOI":"10.1016\/j.cclet.2022.107762","article-title":"Design, synthesis, and evaluation of PD-L1 degraders to enhance T cell killing activity against melanoma","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108622_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116110","article-title":"A potent GPX4 degrader to induce ferroptosis in HT1080 cells","volume":"265","author":"Song","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108622_bb0185","first-page":"72","article-title":"Application of PROTACs in target identification and target validation","volume":"3","author":"Liu","year":"2024","journal-title":"Acta Mater Med"},{"key":"10.1016\/j.bioorg.2025.108622_bb0190","first-page":"639","article-title":"Synthesis and in vitro cytotoxic activities of sorafenib derivatives","volume":"49","author":"Wang","year":"2014","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.bioorg.2025.108622_bb0195","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1021\/acs.jmedchem.3c02129","article-title":"An improved PDE6D inhibitor combines with sildenafil to inhibit KRAS mutant Cancer cell growth","volume":"67","author":"Kaya","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:59:10Z","timestamp":1777463950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"alternative-id":["S0045206825005024"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108622","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An NTCP-mediated liver-targeting chimeras (NTLiverTac) design strategy and its application to hepatoblastoma models","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108622"}}